Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis

Journal of Rheumatology

Volumn 33, Issue 7, 2006, Pages 1293-1298

  Narváez, Javier ^a   Bernad, Berta ^a   Díaz Torné, Cesar ^a   Vilaseca Momplet, Jaime ^b   Zaragoza Montpel, Jordi ^c   Nolla, Joan M ^a   Valverde García, José ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Department of Internal Medicine ^*

^c Laboratory of Clinical Biochemistry   (Spain)

Author keywords

ACTH; Cortisol; Dehydroepiandrosterone sulfate; Giant cell (temporal) arteritis; Inflammation; Polymyalgia rheumatica

Indexed keywords

CORTICOTROPIN; GLUCOCORTICOID; HYDROCORTISONE; PRASTERONE SULFATE;

ADRENAL FUNCTION; ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; EVALUATION; FEMALE; GENDER; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFLAMMATION; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; STATISTICAL SIGNIFICANCE;

ADRENOCORTICOTROPIC HORMONE; AGED; COHORT STUDIES; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; REFERENCE VALUES; TEMPORAL ARTERITIS;

EID: 33745782274     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Weyand CM, Goronzy JJ. Giant cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003;139:505-15.
2. Dharia A, Parker CR Jr. Adrenal androgens and aging. Semin Reprod Med 2004;22:361-8.
3. Nilsson E, De la Torre B, Hedman M, Goobar J, Thörner A. Blood dehydroepiandrosterone sulfate (DHEAS) levels in polymyalgia rheumatica/giant cell arteritis and primary fibromyalgia. Clin Exp Rheumatol 1994;12:415-7.
4. Straub RH, Glück R, Cutolo M. et al. The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology Oxford 2000;39:624-31.
5. Cutolo M, Straub RH. Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease. Clin Exp Rheumatol 2000;18:655-8.
6. Cutolo M, Straub RH, Foppiani L, et al. Adrenal gland hypofunction in active polymyalgia rheumatica. Effect of glucocorticoid treatment on adrenal hormones and interleukin 6. J Rheumatol 2002;29:748-56.
7. Cutolo M, Sulli A, Pizzorni C, et al. Cortisol, dehydroepiandrosterone sulfate, and androstenedione levels in patients with polymyalgia rheumatica during twelve months of glucocorticoid therapy. Ann NY Acad Sci 2002;966:91-6.
8. Cutolo M, Foppiani L, Minuto F. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J Endocrinol Invest 2002;25 (10 Suppl):19-23.
9. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 1993;150:5219-30.
10. Spencer NFL, Norton SD, Harrison LL, Gang-Zhou L, Daynes RA. Dysregulation of IL-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp Gerontol 1996;31:393-408.
11. Straub RH, Konecna L, Hrach S, et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998;83:2012-17.
12. Imrich R. The role of neuroendocrine system in the pathogenesis of rheumatic diseases. Endocr Reg 2002;36:95-106.
13. Bartolomé Pacheco MJ, Amado JA, Lopez-Hoyos M, et al. Hypothalamic-pituitary-adrenocortical axis in patients with polymyalgia rheumatica and giant cell arteritis. Semin Arthritis Rheum 2003;4:266-72.
14. Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984;13:322-8.
15. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
16. Cutolo M, Foppiani L, Prete C, et al. Hypothalamic-pituitary- adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999;26:282-8.
17. Cutolo M, Sulli A, Pizzorni C, Craviotto C, Straub RH. Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis. Ann NY Acad Sci 2003;992:107-17.
18. Kanik KS, Chrousos GP, Schumacher HR, Crane ML, Yarboro CH, Wilder RL. Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation. J Clin Endocrinol Metab 2000;85:1461-6.
19. Kanik KS, Wilder RL. Hormonal alterations in rheumatoid arthritis, including the effects of pregnancy. Rheum Dis Clin North Am 2000;26:805-24.
20. Jungers P, Nahoul K, Pelissier C, Dougados M, Tron F, Bach JF. Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 1982;25:454-7.
21. Lahita RG, Bradlow HL, Ginzler E, Pang S, New M. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987;30:241-8.
22. Straub RH, Zeuner M, Antoniou E, Schölmerich J, Lang B. Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus. J Rheumatol 1996;23:856-61.
23. La Montagna G, Baruffo A, Buono G, Valentini G. Dehydroepiandrosterone sulphate serum levels in systemic sclerosis. Clin Exp Rheumatol 2001;19:21-6.
24. Straub RH, Zeuner M, Lock G, Schölmerich J, Lang B. High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis. Br J Rheumatol 1997;36:426-32.
25. Straub RH, Vogl D, Gross V, Lang B, Scholmerich J, Andus T. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate and cortisol serum levels in patients with chronic inflammatory bowel disease. Am J Gastroenterol 1998;93:2197-202.
26. De la Torre B, Fransson J, Scheynius A. Blood dehydroepiandrosterone sulfate (DHEAS) levels in pemphigoid/pemphigus and psoriasis. Clin Exp Rheumatol 1995;13:345-8.
27. Straub RH, Besedovsky HO. Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J 2003;17:2176-83.
28. Deighton CM, Watson MJ, Walker DJ. Sex hormones in postmenopausal HLA-identical rheumatoid arthritis discordant sibling pairs. J Rheumatol 1992;19:1663-7.
29. Dessein PH, Joffe BI, Stanwix AE, Moomal Z. Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis. Arthritis Res 2001;3:183-8.
30. Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993;36:1286-94.
31. Narvaez J, Nolla Sole JM, Valverde García J, Roig Escofet D. Sex differences in temporal arteritis and polymyalgia rheumatica. J Rheumatol 2002;29:321-5.
32. Nir-Paz R, Gross A, Chajek-Shaul T. Sex differences in giant cell arteritis. J Rheumatol 2002;29:1219-23.
33. Calvo Romero JM, Magro Ledesma D, Ramos Salado JL, et al. Giant cell arteritis: a descriptive study in south-western Spain. An Med Interna 2000;17:67-70.
34. Armona J, Rodriguez Valverde V, Gonzalez Gay MA, et al. Giant cell arteritis. Study of 191 patients. Med Clin Barc 1995;105:734-7.
35. Narvaez J, Nolla Sole JM, Clavaguera MT, Valverde Garcia J, Roig Escofet D. Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis. J Rheumatol 1999;26:1945-52.
36. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica. A 10 year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
37. Ayoub WT, Franklin CM, Torreti D. Polymyalgia rheumatica: duration of therapy and long-term outcome. Am J Med 1985;79:309-15.
38. Ashraf F, Belilos E, Terenci T, Carsons SE. Gender specific differences in treatment outcomes in polymyalgia rheumatica [abstract]. Arthritis Rheum 2000;43 Suppl:1778.
39. Nordborg E, Nordborg C, Malmvall BE, Andersson R, Bengtsson BA. Giant cell arteritis. Rheum Dis Clin North Am 1995;21:1013-26.
40. Liozon E, Fauchais AL, Loustaud V, Vidal E. No significant sex differences in temporal arteritis. J Rheumatol 2004;31:397-9.